Michael Ohanessian has executive experience gained from technology-related businesses with leadership capabilities.
Following a ten-year career at Mobil Oil, he consulted to clients in a range of industries including banking, airlines, mining, packaging, sports, oil and gas, retailing and biotechnology at Boston Consulting Group. He later became chief executive of Vision BioSystems, a division of the former public-listed Vision Systems, where he transformed the business over seven years from a contract manufacturer into a medical diagnostics business with distribution to over 60 countries. Mr Ohanessian was also chief executive of Genetic Technologies and has been part of the investment management and corporate advice team at Lion Capital.